Which is the most common site of synaptic transmission failure in myasthenia gravis?

Explanation

## Pathophysiology of Myasthenia Gravis (MG) ### Definition & Epidemiology Myasthenia gravis is an autoimmune disorder characterized by antibodies against the **nicotinic acetylcholine receptor (AChR)** at the neuromuscular junction, resulting in progressive muscle weakness and fatigability. **High-Yield:** MG is the most common acquired disorder of the NMJ. The primary pathology is **postsynaptic** — at the motor end plate itself. ### Mechanism of AChR Dysfunction ```mermaid flowchart TD A[Autoimmune attack on AChR]:::urgent --> B[Antibody-mediated complement activation] B --> C[Destruction of acetylcholine receptors] C --> D[Reduced AChR density at motor end plate] D --> E[Decreased end plate potential amplitude] E --> F[Failure to reach action potential threshold] F --> G[Muscle weakness & fatigability]:::outcome ``` ### Why the Motor End Plate is the Primary Site | Pathological Feature | Evidence | |----------------------|----------| | **Antibody target** | 80–90% of MG patients have anti-AChR antibodies | | **Receptor loss** | 70–80% reduction in AChR density on electron microscopy | | **Structural changes** | Flattening and simplification of motor end plate | | **Electrophysiology** | Decreased miniature end plate potential (MEPP) amplitude | | **Functional consequence** | EPP falls below threshold → transmission block | **Key Point:** The **safety factor** of the NMJ is normally ~4 (EPP is 4× the threshold needed). In MG, loss of AChRs reduces EPP amplitude, and with repeated stimulation (fatigue), EPP falls below threshold → clinical weakness. ### Clinical Presentation Correlates **Clinical Pearl:** MG symptoms worsen with **repetitive use** (fatigability) because: 1. Presynaptic ACh stores deplete with each action potential 2. Fewer AChRs available → EPP already reduced 3. Combination → transmission failure during sustained activity ### Diagnostic Confirmation 1. **Antibody serology:** Anti-AChR antibodies (80–90% sensitivity in generalized MG) 2. **Electromyography (EMG):** Decremental response (characteristic of NMJ disorders) 3. **Edrophonium or neostigmine test:** Acetylcholinesterase inhibitors ↑ ACh → temporary improvement (confirms postsynaptic pathology) 4. **Repetitive nerve stimulation (RNS):** Shows decremental response **Mnemonic:** **MG = Motor End plate Gone** — The motor end plate is where the antibodies strike; AChRs are destroyed, not the presynaptic terminal or the muscle fiber itself.